沙特阿拉伯的体重指数类别的饮食态度:一个横截面研究
Hayat Alzahrani1, Manal Naseeb2, Alyaa M Zagzoog3
1Department of Food Science and Nutrition, College of Food and Agricultural Sciences, King Saud University, Riyadh, Saudi Arabia.
Frontiers in nutrition
|March 2, 2026
概括
沙特成年人可能患有饮食障碍,体重过重的风险更高. 饮食态度可能反映了社会敏感性而不是病理性,这表明需要对文化敏感的公共卫生策略.
科学领域:
- 营养与饮食学 营养与饮食学
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 体重通过心理,行为和社会文化因素与饮食失调有关.
- 沙特阿拉伯的研究表明,饮食障碍风险增加,特别是在女大学生中.
- 身体质量指数 (BMI) 类别和特定的饮食态度等级之间的关联尚未得到充分研究.
研究的目的:
- 评估不同BMI类别的沙特成年人的饮食态度.
- 检查饮食态度与BMI之间的关联.
- 确定与饮食态度和BMI相关的社会人口统计和代谢风险因素.
主要方法:
- 使用社交媒体便利抽样对404名沙特成年人 (≥18岁) 进行横截面研究.
- 体重指数 (BMI) 的类别:超重 (25.0-29.9 kg/m2) 和肥胖 (≥30 kg/m2).
- 使用阿拉伯饮食态度测试 (EAT-26) 评估饮食态度;进行多项和线性回归分析.
主要成果:
- 男性的平均BMI比女性高 (26.5 ± 5.4),比女性高 (24.7 ± 5.5).
- 可能患有饮食障碍的参与者患超重的风险显著增加 (RRR = 5.90).
- "他人的感知"和"口腔控制"分量级的较高得分与BMI相反相关.
结论:
- 沙特阿拉伯的社会文化变化影响了饮食态度和身体形象问题.
- 超重个体的饮食态度可能表明社会敏感性和自我调节,不一定是病理.
- 建议对文化敏感的查和尊重身体的策略来支持福祉和健康的体重.
更多相关视频
06:48Author Spotlight: Advancements in 3D Optical Imaging for Comprehensive Body Composition Assessment in Modern Research
Published on: June 7, 2024
2.1K
04:43COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
585
相关概念视频
Surveys
17.1K
Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
17.1K
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Self-Schemas
36.5K
In general, a schema is a mental construct consisting of a cluster or collection of related concepts (Bartlett, 1932). There are many different types of schemata, and they all have one thing in common: schemata are a method of organizing information that allows the brain to work more efficiently. When a schema is activated, the brain makes immediate assumptions about the person or object being observed.
36.5K
Drug Dosing: Obese Patients
316
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
316
Bias in Epidemiological Studies
1.5K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
326
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
326
